1. an injection of Glucagon-Like Peptide-1 (GLP-1) hormone is the new medicine on the block that is used to treat both diabetes and obesity!
"GLP-1 injection mainly targets the pancreas where it stimulates the beta cells to produce more insulin and targets the alpha cells so that less glucose is produced. By this twin action, it sets a new glucose regulatory mechanism in the body helping to control both diabetes and obesity".
2. 'Orlistat' had been found to be the most effective in obesity management.
3. Open from all sides and noise free New MRI for claustrophobic patients, is specifically meant for scanning joints and the spine. It is not meant for head and abdomen MRI scanning. As compared to the conventional MRI that costs Rs 6,000, G-scan costs Rs 9,000, and it takes about 40 minutes for a scan instead of the 20 minutes in the conventional MRI.
4. The health ministry on Friday (18-3-2011) issued a notification, for the second time, ordering a blanket ban on the sale and manufacture of six categories of drugs, including Nimesulide formulations for pediatric use and Sibutramine, a popular anti-obesity drug.
The government has also banned the drugs Gatifloxacin and Tegaserod with immediate effect, saying their use poses health risks. Gatifloxacin is an antibiotic and Tegaserod is meant to treat irritable bowel syndrome.
"GLP-1 injection mainly targets the pancreas where it stimulates the beta cells to produce more insulin and targets the alpha cells so that less glucose is produced. By this twin action, it sets a new glucose regulatory mechanism in the body helping to control both diabetes and obesity".
2. 'Orlistat' had been found to be the most effective in obesity management.
3. Open from all sides and noise free New MRI for claustrophobic patients, is specifically meant for scanning joints and the spine. It is not meant for head and abdomen MRI scanning. As compared to the conventional MRI that costs Rs 6,000, G-scan costs Rs 9,000, and it takes about 40 minutes for a scan instead of the 20 minutes in the conventional MRI.
4. The health ministry on Friday (18-3-2011) issued a notification, for the second time, ordering a blanket ban on the sale and manufacture of six categories of drugs, including Nimesulide formulations for pediatric use and Sibutramine, a popular anti-obesity drug.
The government has also banned the drugs Gatifloxacin and Tegaserod with immediate effect, saying their use poses health risks. Gatifloxacin is an antibiotic and Tegaserod is meant to treat irritable bowel syndrome.
5. STEM CELL RESEARCH ,GENE THERAPY, NANO DRUG DELIVERY ARE THE FUTURE in health care.
6. A simple laboratory test to measure protein C a natural anti-blood-clotting substance that also reflects the level of inflammation in the body may offer a useful new indicator of the severity of illness and risk of death among critically ill patients.
Comments
Post a Comment